Kerstin Lühn

The gene defective in leukocyte adhesion deficiency II encodes a putative GDP-fucose transporter

Kerstin Lühn, Martin K. Wild, Matthias Eckhardt et al. · Nature Genetics · 2001 · 337 citations

Inflammation, Disease Mechanism, Putative Gdp-fucose Transporter +14

Safety and Immunogenicity of Novel Adenovirus Type 26– and Modified Vaccinia Ankara–Vectored Ebola Vaccines

Iain Milligan, Malick M. Gibani, Richard P. Sewell et al. · JAMA · 2016 · 321 citations

Correction of Leukocyte Adhesion Deficiency Type II With Oral Fucose

Thorsten Marquardt, Kerstin Lühn, Geetha Srikrishna et al. · Blood · 1999 · 278 citations

Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial

Andrew J. Pollard, Odile Launay, Jean‐Daniel Lelièvre et al. · The Lancet Infectious Diseases · 2020 · 164 citations · Full text

Vaccination, Vaccine Safety, Vaccinology +8

Safety and Immunogenicity of a 2-Dose Heterologous Vaccination Regimen With Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: 12-Month Data From a Phase 1 Randomized Clinical Trial in Uganda and Tanzania

Zacchaeus Anywaine, Hilary Whitworth, Pontiano Kaleebu et al. · The Journal of Infectious Diseases · 2019 · 148 citations · Full text